Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOCRATES: Ticagrelor vs Aspirin for Secondary Prevention After Stroke or TIA
NCT01994720Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 33
01
Overview
A Phase 3 trial of ticagrelor in ischemic stroke, transient ischaemic attack (TIA), sponsored by AstraZeneca. Started Jan 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on NCT01994720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01994720.